Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
17.65
+0.58 (3.40%)
Oct 20, 2025, 4:00 PM EDT - Market closed
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $2.21 billion as of October 21, 2025. Its market cap has increased by 120.48% in one year.
Market Cap
2.21B
Enterprise Value
2.17B
1-Year Change
120.48%
Ranking
Category
Stock Price
$17.65
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $2.21B, an increase of 271.75%. That is a compound annual growth rate of 14.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 2.18B | -3.35% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |